In 2012 UBC CPD received the Royal College Accredited CPD Provider Innovation Award for This Changed My Practice.
Archives by date
You are browsing the site archives by date.
When vulvovaginal atrophy involves loss of genital sexual sensitivity: local (vaginal) dehydroepiandrosterone (DHEA) shows promise
By Dr. Rosemary Basson on December 3, 2013
Recent studies have shown that the local delivery of the main precursor hormone of testosterone and estrogen, dehydroepiandrosterone (DHEA) effectively treats dyspareunia and dryness from VVA and does not increase serum levels of estrogen and testosterone.